July 10, 2020

The Niche

Knoepfler lab stem cell blog

CRISPR clinical use

4 min read

The international stem cell policy and ethics think tank, the Hinxton Group, weighed in yesterday on heritable human genetic modification with a new policy statement. The Hinxton statement is in many ways in agreement with the Baltimore, et al. Nature paper proposing a “prudent path forward” for human germline genetic modification, which came out of the Napa Meeting earlier this year. However, while several of the Napa authors have now thrown their public support behind a clinical pause or moratorium on heritable human modification …Read More